Short Interest in Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Drops By 8.2%

Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) was the target of a large decrease in short interest in the month of October. As of October 31st, there was short interest totalling 36,800 shares, a decrease of 8.2% from the October 15th total of 40,100 shares. Based on an average daily volume of 11,400 shares, the days-to-cover ratio is presently 3.2 days.

Conduit Pharmaceuticals Trading Down 18.0 %

NASDAQ CDTTW traded down $0.00 during trading hours on Monday, hitting $0.01. 7,417 shares of the company’s stock were exchanged, compared to its average volume of 15,710. Conduit Pharmaceuticals has a 1-year low of $0.01 and a 1-year high of $0.16. The stock has a 50-day simple moving average of $0.01 and a 200 day simple moving average of $0.03.

Conduit Pharmaceuticals Company Profile

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.